标题
Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer
作者
关键词
-
出版物
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 90, Issue 10, Pages 1121-1132
出版商
Springer Nature
发表日期
2012-03-15
DOI
10.1007/s00109-012-0885-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
- (2011) Y. X. Zhu et al. BLOOD
- XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments
- (2010) T. Bagratuni et al. BLOOD
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase II Study of Capecitabine in Combination With Thalidomide in Patients With Metastatic Breast Cancer
- (2010) Howard A. Burris et al. CANCER INVESTIGATION
- Lenalidomide down regulates the production of interferon-γ and the expression of inhibitory cytotoxic receptors of human Natural Killer cells
- (2010) Nicolas Dauguet et al. CELLULAR IMMUNOLOGY
- Molecular genetics of prostate cancer: new prospects for old challenges
- (2010) M. M. Shen et al. GENES & DEVELOPMENT
- Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study
- (2010) Jean A. Hurteau et al. GYNECOLOGIC ONCOLOGY
- High expression levels of the mammalian target of rapamycin inhibitorDEPTORare predictive of response to thalidomide in myeloma
- (2010) Kevin D. Boyd et al. LEUKEMIA & LYMPHOMA
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- Cul4A is an oncogene in malignant pleural mesothelioma
- (2009) Ming-Szu Hung et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non–Small-Cell Lung Cancer
- (2009) Siow Ming Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
- (2009) H Quach et al. LEUKEMIA
- CDK Inhibitor p21 Is Degraded by a Proliferating Cell Nuclear Antigen-coupled Cul4-DDB1Cdt2Pathway during S Phase and after UV Irradiation
- (2008) Hideo Nishitani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols
- (2008) Alonso V. Pacheco et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Randomized Trial of Adjuvant Thalidomide Versus Observation in Patients With Completely Resected High-Risk Renal Cell Carcinoma
- (2008) Vitaly Margulis et al. UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now